Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084

By sjmartinez • January 3, 2025

Delany-Moretlwe S, Hanscom B, Guo X, Nkabiito C, Mandima P, Nahirya PN, Mpendo J, Bhondai-Mhuri M, Mgodi N, Berhanu R, Farrior J, Piwowar-Manning E, Ford SL, Hendrix CW, Rinehart AR, Rooney JF, Adeyeye A, Landovitz RJ, Cohen MS, Hosseinipour MC, Marzinke MA; HPTN 084 Study Team. Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084. J Int AIDS Soc. 2025 Jan;28(1):e26401. doi: 10.1002/jia2.26401. PMID: 39748218.

Tags: Cabotegravir, HIV prevention, Infectious Diseases, long‐acting, pregnancy, PrEP, Publications, Women

Prognostic Biomarker Signature of Relapse in Neuromyelitis Optica Spectrum Disorders in the CIRCLES Observational Study

Bach E, Breschi A, Wang Y, Carroll MK, Luk W, Han A, Short S, Cimermančič P, Drake KA, Cook LJ, Snyder T, Smith TJ, Yeaman[...]

Bundibugyo Ebola in DR Congo and Uganda: community-centred response must be operational, not rhetorical

Mbala-Kingebeni P, Boum Y, Fallah MP, Wilson B, Belizaire MR, Hoff NA, Sprecher A, Hensley LE, Kindrachuk J, Rimoin AW. Bundibugyo Ebola in DR Congo[...]

Hair Testing to Detect Long-term Methamphetamine Use in People Living with and without HIV

Appa A, Javanbakht M, Spinelli M, Heise MJ, Steiner G, Bolanos R, Okochi H, Gorbach P, Gandhi M. Hair Testing to Detect Long-term Methamphetamine Use[...]